Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs VICR✓SelectedUSD · VICRGSK vs VICR performance historyLatest closeAs of-2.32%11/17
Stock and ETF performance explorer

GSK vs VICR

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+1,619.1%
VICR return
+9,228.3%
Excess return
-7,609.2%
Maximum drawdown
-55.2%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioVICRExcessAlpha
1D-2.3%-1.1%-1.3%-2.3%
7D-3.0%-10.3%+7.3%-2.3%
30D+0.4%-24.3%+24.6%+1.7%
3M-1.2%-42.8%+41.6%+1.3%
6M+0.9%-47.0%+48.0%+2.7%
YTD+4.0%+32.3%-28.3%-2.4%
1Y+7.3%+66.5%-59.2%-1.1%
3Y+57.1%+269.4%-212.3%+31.3%
5Y+43.0%-11.0%+54.0%+28.0%
10Y+103.1%+882.8%-779.8%+39.6%
All+1,619.1%+9,228.3%-7,609.2%+613.8%

Cumulative growth

Daily Returns

Daily percentage return beside VICR.

Daily Out/Under-Performance

Portfolio return minus VICR return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × VICR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded VICR wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling